Study title:
AN 15142393 Medline 20070101.
TI A chart review of cyproheptadine for stimulant-induced weight loss.
SO Journal of child and adolescent psychopharmacology, {J-Child-Adolesc- Psychopharmacol}, Spring 2004, vol. 14, no. 1, p. 65-73, ISSN: 1044-5463.
AU Daviss-W-Burleson, Scott-John.
IN Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA. YR 2004.AN 15142393 Medline 20070101.
TI A chart review of cyproheptadine for stimulant-induced weight loss.
SO Journal of child and adolescent psychopharmacology, {J-Child-Adolesc- Psychopharmacol}, Spring 2004, vol. 14, no. 1, p. 65-73, ISSN: 1044-5463.
AU Daviss-W-Burleson, Scott-John.
IN Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|